Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA)

Diabetes and Vascular Disease Research

Volumn 6, Issue 1, 2009, Pages 40-42

  Kreis, Andreas J ^a   Wong, Tien Yin ^a   Islam, F M Amirul ^a   Klein, Ronald ^b   Klein, Barbara E K ^b   Cotch, Mary Frances ^c   Jenkins, Alicia J ^a   Shea, Steven ^d   Wang, Jie Jin ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diabetic retinopathy; NMR lipoprotein; Retinal photography; Type 2 diabetes

Indexed keywords

LIPOPROTEIN;

AGE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ETHNICITY; EYE PHOTOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RISK FACTOR;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ETHNIC GROUPS; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNETIC RESONANCE SPECTROSCOPY; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

EID: 59149099332     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2009.008     Document Type: Article

References (10)

1. Keech AC, Mitchell P, Summanen PA et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007;370:1687-97.
2. Dodson PM. Diabetic retinopathy: treatment and prevention. Diabetes Vasc Dis Res 2007;4(suppl 3):S9-S11; doi:10.3132/ dvdr.2007.051.
3. de Boer IH, Astor BC, Kramer H et al. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2008;197:407-14.
4. Ding SY, Tigno XT, Hansen BC. Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism 2007;56: 838-46.
5. Jenkins AJ, Lyons TJ, Zheng D et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care 2003;26:810-18.
6. Bild D, Bluemke D. The Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-81.
7. Wong TY, Klein R, Islam FM et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006; 141:446-55.
8. Group DRSR. Design, methods and baseline results: A modification of the Airlie House Classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy Study Group. Invest Ophthalmol Vis Sci 1981;21 QRS Report 7):1b-22b.
9. Festa A, Williams K, Hanley AJ et al. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 2005; 111:3465-72.
10. Mora S, Szklo M, Otvos JD et al. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007;192:211-17.